atorvastatin has been researched along with Endotoxemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Medvedeva, EA; Seleznev, EI; Shchukin, IuV | 1 |
Brookes, ZL; Brown, NJ; Hellewell, PG; McGown, CC; Ross, JJ | 1 |
Ebdrup, L; Granfeldt, A; Hokland, M; Krog, J; Larsen, PØ; Tønnesen, E; Vestergaard, C | 1 |
1 trial(s) available for atorvastatin and Endotoxemia
Article | Year |
---|---|
[Prevention of cardiovascular complications in patients undergoing aortic-iliac reconstructions by correction of inflammation and endotoxemia].
Topics: Aorta, Abdominal; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Endotoxemia; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iliac Artery; Inflammation; Middle Aged; Postoperative Complications; Pyrroles; Treatment Outcome; Vascular Surgical Procedures | 2013 |
2 other study(ies) available for atorvastatin and Endotoxemia
Article | Year |
---|---|
Atorvastatin reduces endotoxin-induced microvascular inflammation via NOSII.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Capillary Permeability; Cell Adhesion; Endothelium, Vascular; Endotoxemia; Gene Expression; Intravital Microscopy; Leukocytes; Lipopolysaccharides; Male; Microcirculation; Microvessels; Nitric Oxide Synthase Type II; Rats, Wistar; Vasculitis | 2015 |
Leukocyte, plasma, and organ-associated cytokine profiles in an animal model of acute inflammation.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Cytokines; Disease Models, Animal; Down-Regulation; Endotoxemia; Female; Heart; Heptanoic Acids; Inflammation Mediators; Kidney; Leukocytes; Lipopolysaccharides; Myocardium; Organ Specificity; Pyrroles; Random Allocation; Swine; Up-Regulation | 2008 |